BactiQuant AS (FRA:9JX) 3-Year Revenue Growth Rate : 28.60% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BactiQuant AS 3-Year Revenue Growth Rate?

BactiQuant AS's Revenue per Share for the six months ended in Jun. 2024 was €0.02.

During the past 12 months, BactiQuant AS's average Revenue per Share Growth Rate was -42.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 28.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of BactiQuant AS was 31.90% per year. The lowest was 16.60% per year. And the median was 28.60% per year.

Competitive Comparison of BactiQuant AS's 3-Year Revenue Growth Rate

For the Pollution & Treatment Controls subindustry, BactiQuant AS's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BactiQuant AS's 3-Year Revenue Growth Rate Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, BactiQuant AS's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where BactiQuant AS's 3-Year Revenue Growth Rate falls into.

BactiQuant AS 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

BactiQuant AS (FRA:9JX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

BactiQuant AS 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of BactiQuant AS's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BactiQuant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » BactiQuant AS (FRA:9JX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BACTIQ:Denmark

Address

Blokken 75, Birkeroed, DNK, DK-3460

Website

https://www.bactiquant.com

BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. The technology supports four of the global goals which are access to clean water, sustainability in industry, responsible production and consumption, and the protection of marine life. It serves a wide range of customers and trades, ranging from salmon farmers to oil and gas companies and water distributors.

BactiQuant AS Headlines

No Headlines